Your browser doesn't support javascript.
loading
Epigenetic regulation during cancer transitions across 11 tumour types.
Terekhanova, Nadezhda V; Karpova, Alla; Liang, Wen-Wei; Strzalkowski, Alexander; Chen, Siqi; Li, Yize; Southard-Smith, Austin N; Iglesia, Michael D; Wendl, Michael C; Jayasinghe, Reyka G; Liu, Jingxian; Song, Yizhe; Cao, Song; Houston, Andrew; Liu, Xiuting; Wyczalkowski, Matthew A; Lu, Rita Jui-Hsien; Caravan, Wagma; Shinkle, Andrew; Naser Al Deen, Nataly; Herndon, John M; Mudd, Jacqueline; Ma, Cong; Sarkar, Hirak; Sato, Kazuhito; Ibrahim, Omar M; Mo, Chia-Kuei; Chasnoff, Sara E; Porta-Pardo, Eduard; Held, Jason M; Pachynski, Russell; Schwarz, Julie K; Gillanders, William E; Kim, Albert H; Vij, Ravi; DiPersio, John F; Puram, Sidharth V; Chheda, Milan G; Fuh, Katherine C; DeNardo, David G; Fields, Ryan C; Chen, Feng; Raphael, Benjamin J; Ding, Li.
Afiliação
  • Terekhanova NV; Department of Medicine, Washington University in St Louis, St Louis, MO, USA.
  • Karpova A; McDonnell Genome Institute, Washington University in St Louis, St Louis, MO, USA.
  • Liang WW; Department of Medicine, Washington University in St Louis, St Louis, MO, USA.
  • Strzalkowski A; McDonnell Genome Institute, Washington University in St Louis, St Louis, MO, USA.
  • Chen S; Department of Medicine, Washington University in St Louis, St Louis, MO, USA.
  • Li Y; McDonnell Genome Institute, Washington University in St Louis, St Louis, MO, USA.
  • Southard-Smith AN; Department of Computer Science, Princeton University, Princeton, NJ, USA.
  • Iglesia MD; Department of Medicine, Washington University in St Louis, St Louis, MO, USA.
  • Wendl MC; McDonnell Genome Institute, Washington University in St Louis, St Louis, MO, USA.
  • Jayasinghe RG; Department of Medicine, Washington University in St Louis, St Louis, MO, USA.
  • Liu J; McDonnell Genome Institute, Washington University in St Louis, St Louis, MO, USA.
  • Song Y; Department of Medicine, Washington University in St Louis, St Louis, MO, USA.
  • Cao S; McDonnell Genome Institute, Washington University in St Louis, St Louis, MO, USA.
  • Houston A; Department of Medicine, Washington University in St Louis, St Louis, MO, USA.
  • Liu X; McDonnell Genome Institute, Washington University in St Louis, St Louis, MO, USA.
  • Wyczalkowski MA; Department of Medicine, Washington University in St Louis, St Louis, MO, USA.
  • Lu RJ; McDonnell Genome Institute, Washington University in St Louis, St Louis, MO, USA.
  • Caravan W; Department of Medicine, Washington University in St Louis, St Louis, MO, USA.
  • Shinkle A; McDonnell Genome Institute, Washington University in St Louis, St Louis, MO, USA.
  • Naser Al Deen N; Department of Medicine, Washington University in St Louis, St Louis, MO, USA.
  • Herndon JM; McDonnell Genome Institute, Washington University in St Louis, St Louis, MO, USA.
  • Mudd J; Department of Medicine, Washington University in St Louis, St Louis, MO, USA.
  • Ma C; McDonnell Genome Institute, Washington University in St Louis, St Louis, MO, USA.
  • Sarkar H; Department of Medicine, Washington University in St Louis, St Louis, MO, USA.
  • Sato K; McDonnell Genome Institute, Washington University in St Louis, St Louis, MO, USA.
  • Ibrahim OM; Department of Medicine, Washington University in St Louis, St Louis, MO, USA.
  • Mo CK; McDonnell Genome Institute, Washington University in St Louis, St Louis, MO, USA.
  • Chasnoff SE; Department of Medicine, Washington University in St Louis, St Louis, MO, USA.
  • Porta-Pardo E; Department of Medicine, Washington University in St Louis, St Louis, MO, USA.
  • Held JM; McDonnell Genome Institute, Washington University in St Louis, St Louis, MO, USA.
  • Pachynski R; Department of Medicine, Washington University in St Louis, St Louis, MO, USA.
  • Schwarz JK; McDonnell Genome Institute, Washington University in St Louis, St Louis, MO, USA.
  • Gillanders WE; Department of Medicine, Washington University in St Louis, St Louis, MO, USA.
  • Kim AH; McDonnell Genome Institute, Washington University in St Louis, St Louis, MO, USA.
  • Vij R; Department of Medicine, Washington University in St Louis, St Louis, MO, USA.
  • DiPersio JF; Department of Medicine, Washington University in St Louis, St Louis, MO, USA.
  • Puram SV; McDonnell Genome Institute, Washington University in St Louis, St Louis, MO, USA.
  • Chheda MG; Department of Surgery, Washington University in St Louis, St Louis, MO, USA.
  • Fuh KC; Siteman Cancer Center, Washington University in St Louis, St Louis, MO, USA.
  • DeNardo DG; Department of Surgery, Washington University in St Louis, St Louis, MO, USA.
  • Fields RC; Department of Computer Science, Princeton University, Princeton, NJ, USA.
  • Chen F; Department of Computer Science, Princeton University, Princeton, NJ, USA.
  • Raphael BJ; Department of Medicine, Washington University in St Louis, St Louis, MO, USA.
  • Ding L; McDonnell Genome Institute, Washington University in St Louis, St Louis, MO, USA.
Nature ; 623(7986): 432-441, 2023 Nov.
Article em En | MEDLINE | ID: mdl-37914932
ABSTRACT
Chromatin accessibility is essential in regulating gene expression and cellular identity, and alterations in accessibility have been implicated in driving cancer initiation, progression and metastasis1-4. Although the genetic contributions to oncogenic transitions have been investigated, epigenetic drivers remain less understood. Here we constructed a pan-cancer epigenetic and transcriptomic atlas using single-nucleus chromatin accessibility data (using single-nucleus assay for transposase-accessible chromatin) from 225 samples and matched single-cell or single-nucleus RNA-sequencing expression data from 206 samples. With over 1 million cells from each platform analysed through the enrichment of accessible chromatin regions, transcription factor motifs and regulons, we identified epigenetic drivers associated with cancer transitions. Some epigenetic drivers appeared in multiple cancers (for example, regulatory regions of ABCC1 and VEGFA; GATA6 and FOX-family motifs), whereas others were cancer specific (for example, regulatory regions of FGF19, ASAP2 and EN1, and the PBX3 motif). Among epigenetically altered pathways, TP53, hypoxia and TNF signalling were linked to cancer initiation, whereas oestrogen response, epithelial-mesenchymal transition and apical junction were tied to metastatic transition. Furthermore, we revealed a marked correlation between enhancer accessibility and gene expression and uncovered cooperation between epigenetic and genetic drivers. This atlas provides a foundation for further investigation of epigenetic dynamics in cancer transitions.
Assuntos

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Regulação Neoplásica da Expressão Gênica / Epigênese Genética / Neoplasias Limite: Humans Idioma: En Revista: Nature Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Regulação Neoplásica da Expressão Gênica / Epigênese Genética / Neoplasias Limite: Humans Idioma: En Revista: Nature Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos